Insights
All
Podcast
PR & Media
Blog
Podcast
31/03/2026
How Durability Builds a $4.8B Biotech Copy
For this episode of The End Podcast, Biorce CEO Pedro Coelho sits down with Edwin Moses, former CEO of Ablynx.
Blog
30/03/2027
EU AI Act for pharma and biotech Copy
The EU AI Act is becoming fully operational in August 2026. But what are the implications of the EU AI Act for pharma at this stage?
PR & Media
02/12/2025
AI HealthTech Pioneer Biorce Copy
Biorce expands its U.S. footprint and AI R&D operations by opening a new office in Austin, Texas. In Europe, Biorce is already rapidly transforming how Phase I–III clinical trials—up to market approval—are developed.
PR & Media
02/12/2025
AI HealthTech Pioneer Biorce
Biorce expands its U.S. footprint and AI R&D operations by opening a new office in Austin, Texas. In Europe, Biorce is already rapidly transforming how Phase I–III clinical trials—up to market approval—are developed.
Blog
30/03/2027
EU AI Act for pharma and biotech
The EU AI Act is becoming fully operational in August 2026. But what are the implications of the EU AI Act for pharma at this stage?
Podcast
31/03/2026
How Durability Builds a $4.8B Biotech
For this episode of The End Podcast, Biorce CEO Pedro Coelho sits down with Edwin Moses, former CEO of Ablynx.
